These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 22017446

  • 1. The management of gastrointestinal stromal tumors: a model for targeted and multidisciplinary therapy of malignancy.
    Joensuu H, DeMatteo RP.
    Annu Rev Med; 2012; 63():247-58. PubMed ID: 22017446
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Multidisciplinary treatment of gastrointestinal stromal tumors.
    Kingham TP, DeMatteo RP.
    Surg Clin North Am; 2009 Feb; 89(1):217-33, x. PubMed ID: 19186237
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gastrointestinal stromal tumor: 5 years later.
    van der Zwan SM, DeMatteo RP.
    Cancer; 2005 Nov 01; 104(9):1781-8. PubMed ID: 16136600
    [Abstract] [Full Text] [Related]

  • 10. Gastrointestinal stromal tumor and its targeted therapeutics.
    Dupart J, Zhang W, Trent JC.
    Chin J Cancer; 2011 May 01; 30(5):303-14. PubMed ID: 21527063
    [Abstract] [Full Text] [Related]

  • 11. Developments in targeted therapy of advanced gastrointestinal stromal tumors.
    Rutkowski P, Symonides M, Zdzienicki M, Siedlecki JA.
    Recent Pat Anticancer Drug Discov; 2008 Jun 01; 3(2):88-99. PubMed ID: 18537751
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Critical update and emerging trends in imatinib treatment for gastrointestinal stromal tumor.
    De Giorgi U, Pupi A, Turrisi G, Montenora I, Morini S, Fayyaz M, De Simone M, Fiorentini G.
    Rev Recent Clin Trials; 2007 Jan 01; 2(1):43-8. PubMed ID: 18473987
    [Abstract] [Full Text] [Related]

  • 16. Gastrointestinal stromal tumors: imatinib and beyond.
    Schnadig ID, Blanke CD.
    Curr Treat Options Oncol; 2006 Nov 01; 7(6):427-37. PubMed ID: 17032555
    [Abstract] [Full Text] [Related]

  • 17. Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors.
    Lim KH, Huang MJ, Chen LT, Wang TE, Liu CL, Chang CS, Liu MC, Hsieh RK, Tzen CY.
    Med Oncol; 2008 Nov 01; 25(2):207-13. PubMed ID: 18488160
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
    Gold JS, Dematteo RP.
    Ann Surg; 2006 Aug 01; 244(2):176-84. PubMed ID: 16858179
    [Abstract] [Full Text] [Related]

  • 20. Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.
    Agaram NP, Wong GC, Guo T, Maki RG, Singer S, Dematteo RP, Besmer P, Antonescu CR.
    Genes Chromosomes Cancer; 2008 Oct 01; 47(10):853-9. PubMed ID: 18615679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.